Stock Building Supply to Present at Upcoming Investor Conferences

RALEIGH, N.C., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Stock Building Supply Holdings, Inc. (Nasdaq: STCK) (the "Company"), a large, diversified lumber and building materials distributor and solutions provider that sells primarily to new construction and remodeling contractors, today announced that Jeff Rea, President and Chief Executive Officer, and Jim Major, Executive Vice President and Chief Financial Officer, are scheduled to present at the following conferences:

• Robert W. Baird Industrial Conference at the Four Seasons Hotel, in Chicago, Illinois on Tuesday, November 11, 2014 at 2:00 pm eastern time  
• Stephens Inc. Fall Investment Conference at the New York Palace Hotel, in New York, New York on Wednesday, November 12, 2014 at 1:00 pm eastern time

Real-time and archived audio broadcasts of the conference presentations will be available for internet users and can be accessed on the Company's investor relations website: ir.stocksupply.com.

About Stock Building Supply

Stock Building Supply operates in 21 metropolitan areas in 14 states primarily in the South and West regions of the United States (as defined by the U.S. Census Bureau). Today, we serve our customers from 68 strategically located facilities. We offer a broad range of products, including lumber and lumber sheet goods, millwork, doors, flooring, windows, structural components, engineered wood products, trusses, wall panels and other exterior products. Our customer base includes production homebuilders, custom homebuilders and remodeling contractors.

CONTACT: Investor Relations Contact
         Stock Building Supply Holdings, Inc.
         Mark Necaise
         (919) 431-1021
         or
         Solebury Communications Group LLC
         Richard Zubek

Source: Stock Building Supply Holdings, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
• Halmont Properties Corporation Second Quarter Results
• Revved Digital Releases 2026 Home Service Marketing Benchmark Report for Contractors